ALLMedicine™ Giardiasis Center
Research & Reviews 295 results
https://doi.org/10.1007/s10875-022-01299-1 10.1016/j.jaci.2013.12.1077 10.1007/s10875-019-00737-x 10.2147/CEG.S136803 10.14309/ajg.0000000000000140 10.1097/PAS.0b013e3180cab60c 10.15761/CCRR.1000149 10.1016/j.annpat.2013.10.019 10.3748/wjg.v18.i19.2430 10.3851/IMP1792 10.1007/BF02358376 10.1172/JCI105259 10.1086/606059 10.1007/s10875-010-9424-3 10.1016/0016-5085(81)90506-0 10.1016/S0022-3476(97)70200-2 10.1002/cyto.b.20432 10.1016/j.mad.2005.11.001 10.1111/cei.12002 10.1007/s11894-016-0491-3 10.1016/j.jpeds.2015.04.061 10.1007/s00246-001-0078-z 10.1172/JCI105656 10.1016/j.jpeds.2018.12.003 10.1007/s12185-017-2349-3 10.1186/s12969-016-0093-5 10.2500/aap.2015.36.3876 10.3748/wjg.14.1630 10.1157/13093278 10.1016/S1081-1206(10)61407-X 10.2169/internalmedicine.43.811 10.1136/heart.89.10.1130 10.1007/s004310000639 10.1007/s004310051220 10.1159/000201124 10.1007/BF01300099 10.1016/S0022-3476(75)80145-4 10.7326/0003-4819-68-2-398 10.1080/00365520802321220 10.1016/S0016-5085(97)70231-2 10.1136/jcp.s3-13.1.15 10.1016/j.diagmicrobio.2018.08.002 10.1111/pai.12734
Journal of Clinical Immunology; Lefèvre G, Germain N et. al.
Jun 24th, 2022 - As protein-losing enteropathy (PLE) can lead to hypogammaglobulinemia and lymphopenia, and since common variable immunodeficiency (CVID) is associated with digestive complications, we wondered if (1) PLE could occur during CVID and (2) specific fe...
https://doi.org/10.1016/j.ijpddr.2022.05.004
International Journal for Parasitology. Drugs and Drug Re... Zheng Y, Müller J et. al.
Jun 19th, 2022 - As there is a continuous need for novel anti-infectives, the present study aimed to fuse two modes of action into a novel 3-nitroimidazo[1,2-b]pyridazine scaffold to improve antiparasitic efficacy. For this purpose, we combined known structural el...
https://doi.org/10.1128/aac.00017-22
Antimicrobial Agents and Chemotherapy; Michaels SA, Hulverson MA et. al.
Jun 16th, 2022 - A phenotypic screen of the ReFRAME compound library was performed to identify cell-active inhibitors that could be developed as therapeutics for giardiasis. A primary screen against Giardia lamblia GS clone H7 identified 85 cell-active compounds a...
https://clinicaltrials.gov/ct2/show/NCT02736968
Jun 3rd, 2022 - This is a phase IIa, randomized, placebo-controlled, single-blinded superiority treatment study in males and non-pregnant females, 18 to 65 years of age who are in good health. This study is designed to compare placebo to once daily doses of 6mg a...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9097065
Parasites & Vectors; Wu Y, Yao L et. al.
May 14th, 2022 - Giardia duodenalis is a common parasitic diarrheal agent in humans, especially in developing countries. The aim of this study was to investigate the prevalence and multilocus genetic characterization of G. duodenalis in patients with diarrhea and ...
Drugs 8 results see all →
Clinicaltrials.gov 10 results
https://clinicaltrials.gov/ct2/show/NCT02736968
Jun 3rd, 2022 - This is a phase IIa, randomized, placebo-controlled, single-blinded superiority treatment study in males and non-pregnant females, 18 to 65 years of age who are in good health. This study is designed to compare placebo to once daily doses of 6mg a...
https://clinicaltrials.gov/ct2/show/NCT04827537
Apr 14th, 2022 - The randomized, double-blinded, placebo-controlled clinical study will be conducted by the Uzbek State University of Physical Education and Sport, Institute of the Chemistry of Plant Substances named acad. S. Yu. Yunusov and Republican Specialized...
https://clinicaltrials.gov/ct2/show/NCT02008903
Nov 9th, 2021 - Eosinophilic esophagitis (EoE) is an increasingly recognized rare disease of children and adults characterized by symptoms including nausea, vomiting, abdominal pain, dysphagia and food impaction that occur in conjunction with esophageal eosinophi...
https://clinicaltrials.gov/ct2/show/NCT02127398
Sep 20th, 2021 - Recurrent colitis due to Clostridium difficile results from disruption of the normal gut flora, and is very difficult to treat. It is now clear that restoration of the normal gut flora is the most effective way to treat recurrent C. difficile coli...
https://clinicaltrials.gov/ct2/show/NCT02942485
Nov 18th, 2020 - Approximately 180 children (age 6 months to 10 years) whose clinical symptoms could be explained by giardiasis and whose fecal samples will test positive for the presence of G.lamblia in Uusimaa laboratory (HUSLAB) will be recruited. The study wil...
News 16 results
https://www.medscape.com/viewarticle/959222
Sep 22nd, 2021 - Evacuees of Afghanistan who have arrived in the United States must be vaccinated against measles and undergo quarantine for 21 days, according to a health advisory issued September 20 by the Centers for Disease Control and Prevention (CDC). At the...
https://www.medscape.com/viewarticle/917065
Aug 21st, 2019 - An otherwise healthy 32-year-old man is diagnosed with giardiasis and prescribed metronidazole. He is scheduled to be the best man at his brother's wedding in 3 days. You must Log In to answer this question
https://reference.medscape.com/viewarticle/882224_6
Jun 29th, 2017 - Standard treatment for giardiasis consists of antibiotic therapy. Metronidazole is the most commonly prescribed antibiotic for this condition. However, metronidazole use has been associated with significant failure rates in clearing parasites from...
https://www.mdedge.com/familymedicine/article/132135/infectious-diseases/video-infectious-enteritis-quadrupled-short-term
Internal Medicine News; Amy Karon
Feb 24th, 2017 - More than 10% of patients developed irritable bowel syndrome (IBS) within a year after infectious enteritis, which gave them a more than fourfold greater risk than that of controls, according to a systematic review and meta-analysis of 45 studies.
https://www.mdedge.com/gihepnews/article/132135/infectious-diseases/video-infectious-enteritis-quadrupled-short-term-risk
Amy Karon, MDedge News
Feb 24th, 2017 - More than 10% of patients developed irritable bowel syndrome (IBS) within a year after infectious enteritis, which gave them a more than fourfold greater risk than that of controls, according to a systematic review and meta-analysis of 45 studies.